Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yu V Vakhabova"'
Publikováno v:
Современная онкология, Vol 12, Iss 2, Pp 54-60 (2010)
Externí odkaz:
https://doaj.org/article/2f2e2228b3dc4b939f52e1d34b2af795
Publikováno v:
Современная онкология, Vol 11, Iss 3, Pp 50-54 (2009)
Внедрение в клиническую практику большого количества эффективных схем цитостатической терапии позволило, с одной стороны, сделать изл
Externí odkaz:
https://doaj.org/article/4b75e30e4d584f1dab4a73f2dcf93114
Autor:
E. O. Ignatova, D. A. Seryak, M. Yu. Fedyanin, A. A. Tryakin, I. A. Pokataev, S. F. Menshikova, Yu. V. Vakhabova, M. S. Karbyshev, K. V. Smirnova, S. A. Tulyandin
Publikováno v:
Успехи молекулярной онкологии, Vol 7, Iss 3, Pp 27-36 (2020)
Epstein–Barr virus (EBV) associated gastric carcinoma is a special form of gastric adenocarcinoma that arises against the background of clonal growth of EBV-infected epithelial cells of the gastric mucosa. This subtype of tumors has unique genetic
Externí odkaz:
https://doaj.org/article/14eaec726b784aa39fac2abcc0fb1713
Autor:
G. G. Khakimova, T. N. Zabotina, A. A. Tryakin, A. A. Borunova, T. V. Davidova, A. E. Kalinin, Yu. V. Vakhabova, E. N. Zakharova, D. V. Tabakov
Publikováno v:
Успехи молекулярной онкологии, Vol 7, Iss 1, Pp 38-46 (2020)
Objective: to study the state of cellular immunity in patients with gastric adenocarcinoma.Materials and methods. From 2017 to 2018, 45 previously untreated patients with gastric adenocarcinoma (25 with stage I–III, 20 with stage IV) received surgi
Externí odkaz:
https://doaj.org/article/0144ea3898ec419baab53385814d0f07
Autor:
E. V. Filonenko, A. N. Urlova, Yu. V. Vakhabova, S. V. Medvedev, O. V. Matorin, N. I. Grigorievykh, A. D. Kaprin
Publikováno v:
Biomedical Photonics, Vol 8, Iss 4, Pp 47-52 (2020)
The results of an 11-year clinical observation and treatment of a patient with stage II basal cell carcinoma of the face (Т2N0M0) are presented. History of the illness is associated with a long (from 2001 to 2008) inadequate treatment, due to the in
Externí odkaz:
https://doaj.org/article/eebaed6ff8eb409187cf66da9db8b3ad
Autor:
N. V. Dobrova, N. N. Semenov, G. M. Manikhas, N. Yu. Antimonik, Yu. V. Vakhabova, S. L. Gutorov
Publikováno v:
Тазовая хирургия и онкология, Vol 0, Iss 4, Pp 50-56 (2015)
The aim of this study was to estimate efficacy of first line chemotherapy with bevacizumab in metastatic colorectal cancer patients and investigate the impact of different prognostic factors on treatment outcome.Methods.During 2004–2008 48 colorect